GlaxoSmithKline Pharmaceuticals share news, announcements and annual reports
NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹2,515.10.
30 Oct: open ₹2,527.60, high ₹2,528.90, low ₹2,479.30
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹42,255 Cr221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 39.56
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 18.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.29%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 50.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 56.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,34965.0% delivered
GlaxoSmithKline Pharmaceuticals routine notices
249 filed, newest first. Page 4 of 5.
Jun 2023
22 Jun · Routine
21 Jun · Routine
19 Jun · Routine
19 Jun · Routine
15 Jun · Routine
7 Jun · Routine
2 Jun · Routine
May 2023
30 May · Routine
26 May · Routine
19 May · Routine
18 May · Routine
18 May · Routine
17 May · Routine
12 May · Routine
5 May · Routine
3 May · Routine
Apr 2023
28 Apr · Routine
21 Apr · Routine
Mar 2023
29 Mar · Routine
27 Mar · Routine
23 Mar · Routine
13 Mar · Routine
9 Mar · Routine
3 Mar · Routine
Feb 2023
10 Feb · Routine
Jan 2023
Dec 2022
15 Dec · Routine
13 Dec · Routine
Nov 2022
28 Nov · Routine
18 Nov · Routine
15 Nov · Routine
11 Nov · Routine
10 Nov · Routine
2 Nov · Routine
2 Nov · Routine
Oct 2022
29 Oct · Routine
27 Oct · Routine
19 Oct · Routine
Sep 2022
29 Sep · Routine
Jul 2022
27 Jul · Routine
Jun 2022
28 Jun · Routine
27 Jun · Routine
15 Jun · Routine
13 Jun · Routine
May 2022
20 May · Routine
18 May · Routine
Mar 2022
31 Mar · Routine
24 Mar · Routine